Area of research
Immunology · Oncology
Research interest
Research interests include Immunotherapy and Immune Responses, Cutaneous Melanoma Detection and Management, Melanoma and MAPK Pathways, and Cancer Immunotherapy and Biomarkers.
Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma
Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy
Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis Prediction
Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients
Oxidized Lipoproteins Promote Resistance to Cancer Immunotherapy Independent of Patient Obesity
Prospective validation of the prognostic 31-gene expression profiling test in primary cutaneous melanoma.
TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy
Review of diagnostic, prognostic, and predictive biomarkers in melanoma
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
Increased Th17 Cells in the Tumor Microenvironment Is Mediated by IL-23 via Tumor-Secreted Prostaglandin E2